Emerging impact of triazoles as anti-tubercular agent

A Sharma, AK Agrahari, S Rajkhowa… - European Journal of …, 2022 - Elsevier
Tuberculosis, a disease of poverty is a communicable infection with a reasonably high
mortality rate worldwide. 10 Million new cases of TB were reported with approx 1.4 million …

Research progress on the synthesis and pharmacology of 1, 3, 4-oxadiazole and 1, 2, 4-oxadiazole derivatives: a mini review

JJ Wang, W Sun, WD Jia, M Bian… - Journal of Enzyme …, 2022 - Taylor & Francis
Oxadiazole is a five-membered heterocyclic compound containing two nitrogen atoms and
one oxygen atom. The 1, 3, 4-oxadiazole and 1, 2, 4-oxadiazole have favourable physical …

Design, synthesis and antitubercular assessment of 1, 2, 3-triazole incorporated thiazolylcarboxylate derivatives

RD Bakale, SM Sulakhe, SL Kasare, BP Sathe… - Bioorganic & Medicinal …, 2024 - Elsevier
Abstract A library of 1, 2, 3-triazole incorporated thiazolylcarboxylate derivatives (7a-q) and
(8a-j) were synthesized and evaluated for their in-vitro antitubercular activity against …

In vitro and in silico exploration of newly synthesized triazolyl- isonicotinohydrazides as potent antitubercular agents

RD Bakale, PS Phatak, SS Rathod… - Journal of …, 2023 - Taylor & Francis
In the present study, we have reported the synthesis of novel isoniazid-triazole derivatives
(4a-r), via the click chemistry approach. The synthesized isoniazid-triazole derivatives have …

Biological importance and synthesis of 1, 2, 3-triazole derivatives: a review

MJ Vaishnani, S Bijani, M Rahamathulla… - … Chemistry Letters and …, 2024 - Taylor & Francis
triazole is a five-member nitrogen-containing heterocyclic compound with diverse biological
activities. A number of 1, 2, 3-triazole-containing FDA-approved drugs are available on the …

A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infection

A Maure, E Lawarée, F Fiorentino, A Pawlik… - PLoS …, 2024 - journals.plos.org
Antituberculosis drugs, mostly developed over 60 years ago, combined with a poorly
effective vaccine, have failed to eradicate tuberculosis. More worryingly, multiresistant …

Novel Antitubercular Agents: Design, Synthesis, Molecular Dynamic and Biological Studies of Pyrazole–1, 2, 4‐Triazole Conjugates

KA Ajin, S Arun Kumar, M Singh… - Chemistry & …, 2023 - Wiley Online Library
Mycobacterium tuberculosis (Mtb) has numerous cell wall and non‐cell wall mediated
receptors for drug action, of which cell wall mediated targets were found to be more …

Searching Anti-Zika Virus Activity in 1H-1,2,3-Triazole Based Compounds

WM Dantas, VNM de Oliveira, DAL Santos, G Seabra… - Molecules, 2021 - mdpi.com
Zika virus (ZIKV) is a mosquito-borne virus belonging to the Flaviviridae family and is
responsible for an exanthematous disease and severe neurological manifestations, such as …

Design, synthesis and molecular docking study of novel triazole–quinazolinone hybrids as antimalarial and antitubercular agents

UV Mhetre, NB Haval, GM Bondle, SS Rathod… - Bioorganic & Medicinal …, 2024 - Elsevier
In a quest to discover new antimalarial and antitubercular drugs, we have designed and
synthesized a series of novel triazole–quinazolinone hybrids. The in vitro screening of the …

[HTML][HTML] 1,2,4-Oxadiazole Derivatives: Physicochemical Properties, Antileishmanial Potential, Docking and Molecular Dynamic Simulations of Leishmania infantum …

DCS Barbosa, VN Holanda, EMA Lima… - Molecules, 2024 - mdpi.com
Visceral leishmaniasis (VL), caused by protozoa of the genus Leishmania, remains a
significant public health concern due to its potentially lethal nature if untreated. Current …